NCT04038996View on ClinicalTrials.gov

The Role of SNP rs2910164 in Patients Treated With Immune Checkpoint Inhibitors

CompletedOBSERVATIONAL

Enrollment

179

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

February 29, 2020

Study Completion Date

February 29, 2020

Conditions

Cancer

All Listed Sponsors

lead

University of Freiburg

OTHER

NCT04038996 - The Role of SNP rs2910164 in Patients Treated With Immune Checkpoint Inhibitors | Biotech Hunter | Biotech Hunter